133 related articles for article (PubMed ID: 11029531)
1. Soluble CD44 splice variants and pelvic lymph node metastasis in ovarian cancer patients.
Stickeler E; Vogl FD; Denkinger T; Mobus VJ; Kreienberg R; Runnebaum IB
Int J Mol Med; 2000 Nov; 6(5):595-601. PubMed ID: 11029531
[TBL] [Abstract][Full Text] [Related]
2. Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients.
Mayer S; zur Hausen A; Watermann DO; Stamm S; Jäger M; Gitsch G; Stickeler E
J Cancer Res Clin Oncol; 2008 Nov; 134(11):1229-35. PubMed ID: 18438684
[TBL] [Abstract][Full Text] [Related]
3. Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Cosio S; Prontera C; Bianchi R; Genazzani AR
Anticancer Res; 1997; 17(6D):4463-6. PubMed ID: 9494551
[TBL] [Abstract][Full Text] [Related]
4. The Serum Assay of Soluble CD44 Standard, CD44 Variant 5, and CD44 Variant 6 in Patients with Gastric Cancer.
Yoo CH; Noh SH
Cancer Res Treat; 2003 Feb; 35(1):3-8. PubMed ID: 26680908
[TBL] [Abstract][Full Text] [Related]
5. Serological evaluation of soluble CD44 in renal cancer.
Kan M; Kanayama H; Naruo S; Tsuji M; Kojima K; Kurokawa Y; Kagawa S
Jpn J Cancer Res; 1996 Nov; 87(11):1191-4. PubMed ID: 9045950
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD44 isoforms in serum as potential markers of metastatic gastric carcinoma.
Harn HJ; Ho LI; Shyu RY; Yuan JS; Lin FG; Young TH; Liu CA; Tang HS; Lee WH
J Clin Gastroenterol; 1996 Mar; 22(2):107-10. PubMed ID: 8742647
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis.
Lackner C; Moser R; Bauernhofer T; Wilders-Truschnig M; Samonigg H; Berghold A; Zatloukal K
Breast Cancer Res Treat; 1998 Jan; 47(1):29-40. PubMed ID: 9493973
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD44 molecules in serum of patients with prostate cancer and benign prostatic hyperplasia.
Jung K; Lein M; Weiss S; Schnorr D; Henke W; Loening S
Eur J Cancer; 1996 Apr; 32A(4):627-30. PubMed ID: 8695265
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD44 splice variants in metastasizing human breast cancer.
Martin S; Jansen F; Bokelmann J; Kolb H
Int J Cancer; 1997 Aug; 74(4):443-5. PubMed ID: 9291436
[TBL] [Abstract][Full Text] [Related]
11. High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer.
Zeimet AG; Widschwendter M; Uhl-Steidl M; Müller-Holzner E; Daxenbichler G; Marth C; Dapunt O
Br J Cancer; 1997; 76(12):1646-51. PubMed ID: 9413956
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
Sliutz G; Tempfer C; Winkler S; Kohlberger P; Reinthaller A; Kainz C
Br J Cancer; 1995 Dec; 72(6):1494-7. PubMed ID: 8519665
[TBL] [Abstract][Full Text] [Related]
13. Predictive relevance of soluble CD44v6 serum levels for the responsiveness to second line hormone- or chemotherapy in patients with metastatic breast cancer.
Kopp R; Classen S; Wolf H; Gholam P; Possinger K; Wilmanns W
Anticancer Res; 2001; 21(4B):2995-3000. PubMed ID: 11712800
[TBL] [Abstract][Full Text] [Related]
14. Low serum levels of soluble CD44 variant 6 are significantly associated with poor prognosis in patients with pancreatic carcinoma.
Gansauge F; Gansauge S; Rau B; Scheiblich A; Poch B; Schoenberg MH; Beger HG
Cancer; 1997 Nov; 80(9):1733-9. PubMed ID: 9351541
[TBL] [Abstract][Full Text] [Related]
15. Cytosol concentrations of CD44 isoforms in breast cancer tissue.
Hefler L; Tempfer C; Haeusler G; Kucera E; Mayerhofer K; Zeillinger R; Reinthaller A; Kainz C
Int J Cancer; 1998 Oct; 79(5):541-5. PubMed ID: 9761127
[TBL] [Abstract][Full Text] [Related]
16. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma.
Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N
Cancer; 1998 Sep; 83(6):1094-101. PubMed ID: 9740073
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of soluble CD44 variant isoforms are elevated in rheumatoid arthritis.
Kittl EM; Haberhauer G; Ruckser R; Selleny S; Rech-Weichselbraun I; Hinterberger W; Bauer K
Rheumatol Int; 1997; 16(5):181-6. PubMed ID: 9032816
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD44 and CD44v6 and prognosis in children with B-cell acute lymphoblastic leukemia.
Amirghofran Z; Asiaee E; Kamazani FM
Asia Pac J Clin Oncol; 2016 Sep; 12(3):e375-82. PubMed ID: 25227983
[TBL] [Abstract][Full Text] [Related]
19. Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features.
Zalewski B
World J Gastroenterol; 2004 Feb; 10(4):583-5. PubMed ID: 14966921
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD44 variants in the serum of patients with urological malignancies.
Lein M; Jung K; Weiss S; Schnorr D; Loening SA
Oncology; 1997; 54(3):226-30. PubMed ID: 9143404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
